EndoTraps
PRIVATE
STATUS
Accelerator/Inc
LATEST DEAL TYPE
$100K
LATEST DEAL AMOUNT
2
INVESTORS
Description
Developer of endothelin-1 traps. The company develops endothelin-1 traps which are antibody-based fusion proteins that could bind and sequester the increased levels of endothelin-1 found in different diseases.
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Pharmaceuticals
Primary Office
- England, United Kingdom
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore EndoTraps’s full profile, request a free trial.
EndoTraps Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | $100K | 00000 | Completed | Startup | ||
| 1. Accelerator/Incubator | 12-Apr-2015 | Completed | Startup |
EndoTraps Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Accelerate Cambridge | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | ||
| Founder.org | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |